"Orphan drug & rare disease - Accelerating access to therapeutic innovation " training course
Thursday, May 11, 2017
On the 11th and 12th of May 2017 in Marseille, France, the EUDIPHARM Claude Bernard University, the F-CRIN labeled service platform Orphandev and the Training & Education Unit of F-CRIN’s Coordination are co-organizing the 4th edition of the "Orphan drug & rare disease - Accelerating access to therapeutic innovation " training course. While the methodology remains the main focus of the program, this year will also be the opportunity to address more specifically the EMA tools in drug development but also the issues around personalized medicine.
This training seminar aims at raising awareness among clinical research actors on drug development specificities for rare diseases: Identify tools for drug development Consolidate practices Apprehend the stakes
This training course is aimed at clinical research professionals, project promoters but also patient associations, involved in rare diseases and in the development of orphan drugs. Participants will discuss and deepen the topics proposed through knowledge capitalization, feedbacks, projection of practices, interactions and exchanges with clinical research actors.